Hao Li1, Zewen Sun1, Rongxin Xiao1, Qingyi Qi2, Xiao Li3, Haiyan Huang4, Xuan Wang5, Jian Zhou1, Zhenfan Wang1, Ke Liu4, Ping Yin2, Fan Yang1, Jun Wang6. 1. Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. 2. Department of Radiology, Peking University People's Hospital, Beijing, China. 3. Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. dr.lixiao@163.com. 4. Berry Oncology Corporation, No. 4 Science Park Road, Changping District, Beijing, China. 5. Department of Cardiac Surgery, Peking University People's Hospital, Beijing, China. 6. Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. wangjun@pkuph.edu.cn.
Abstract
BACKGROUND: This study was designed to unravel the genomic landscape and evolution of early-stage subsolid lung adenocarcinomas (SSN-LUADs) manifesting as pure ground-glass nodules (pGGNs), heterogeneous ground-glass nodules (HGGNs) and part-solid nodules (PSNs). METHODS: Samples subjected to either broad-panel next-generation sequencing (NGS) or whole-exome sequencing (WES) were included. Clinicopathologic and genomic features were compared among pGGN, HGGN and PSN, while tumour evolutionary trajectories and mutational signatures were evaluated in the entire cohort. RESULTS: In total, 247 SSN-LUAD samples subjected to broad-panel NGS and 125 to WES were identified. Compared with PSNs, HGGNs had significantly lower tumour mutation count (P < 0.001), genomic alteration count (P < 0.001), and intra-tumour heterogeneity (P = 0.005). Statistically significant upward trends were observed in alterations involving driver mutations and oncogenic pathways from pGGNs to HGGNs to PSNs. EGFR mutation was proved to be a key early event in the progression of SSN-LUADs, with subsequently two evolutionary trajectories involving either RBM10 or TP53 mutation in the cancer-evolution models. CONCLUSIONS: This study provided evidence for unravelling the previously unknown genomic underpinnings associated with SSN-LUAD evolution from pGGN to HGGN to PSN, proving that HGGN was an intermediate SSN form between pGGN and PSN genetically.
BACKGROUND: This study was designed to unravel the genomic landscape and evolution of early-stage subsolid lung adenocarcinomas (SSN-LUADs) manifesting as pure ground-glass nodules (pGGNs), heterogeneous ground-glass nodules (HGGNs) and part-solid nodules (PSNs). METHODS: Samples subjected to either broad-panel next-generation sequencing (NGS) or whole-exome sequencing (WES) were included. Clinicopathologic and genomic features were compared among pGGN, HGGN and PSN, while tumour evolutionary trajectories and mutational signatures were evaluated in the entire cohort. RESULTS: In total, 247 SSN-LUAD samples subjected to broad-panel NGS and 125 to WES were identified. Compared with PSNs, HGGNs had significantly lower tumour mutation count (P < 0.001), genomic alteration count (P < 0.001), and intra-tumour heterogeneity (P = 0.005). Statistically significant upward trends were observed in alterations involving driver mutations and oncogenic pathways from pGGNs to HGGNs to PSNs. EGFR mutation was proved to be a key early event in the progression of SSN-LUADs, with subsequently two evolutionary trajectories involving either RBM10 or TP53 mutation in the cancer-evolution models. CONCLUSIONS: This study provided evidence for unravelling the previously unknown genomic underpinnings associated with SSN-LUAD evolution from pGGN to HGGN to PSN, proving that HGGN was an intermediate SSN form between pGGN and PSN genetically.
Authors: Giulio Caravagna; Alex Graudenzi; Daniele Ramazzotti; Rebeca Sanz-Pamplona; Luca De Sano; Giancarlo Mauri; Victor Moreno; Marco Antoniotti; Bud Mishra Journal: Proc Natl Acad Sci U S A Date: 2016-06-28 Impact factor: 11.205
Authors: Alexander A Bankier; Heber MacMahon; Jin Mo Goo; Geoffrey D Rubin; Cornelia M Schaefer-Prokop; David P Naidich Journal: Radiology Date: 2017-06-26 Impact factor: 11.105
Authors: Renelle Myers; Michael Brauer; Trevor Dummer; Sukhinder Atkar-Khattra; John Yee; Barbara Melosky; Cheryl Ho; Anna L McGuire; Sophie Sun; Kyle Grant; Alexander Lee; Martha Lee; Weiran Yuchi; Martin Tammemagi; Stephen Lam Journal: J Thorac Oncol Date: 2021-07-10 Impact factor: 15.609
Authors: Yeon Wook Kim; Byoung Soo Kwon; Sung Yoon Lim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Kyung Won Lee; Jae Ho Lee; Jin-Haeng Chung; Eunjeong Ji; Choon-Taek Lee Journal: Thorax Date: 2021-04-15 Impact factor: 9.139